Navigation Links
Senokot(R) Tablets Undergo a Natural Makeover
Date:8/6/2009

t(R) and Senokot-S(R) Tablets will be hitting the shelves in the fall, joining the other Purdue Laxative brands, including Colace (R) Capsules and Peri-Colace(R) Tablets and rounding out the company's comprehensive offerings for relief for occasional constipation.

The Purdue Products L.P. Line of Laxatives

Senokot(R) Tablets and Colace(R) Capsules have been recommended by doctors and pharmacists for more than 50 years for effective, gentle and safe relief from occasional constipation. Colace(R) Capsules, the #1 recommended stool softener brand by doctors and pharmacists, relieves occasional constipation that may be associated with certain medical conditions. Senokot (R)Tablets provide gentle, yet effective relief for occasional constipation associated with diet or lifestyle. The Purdue laxative portfolio includes: Colace(R) Capsules, Peri-Colace(R) Tablets, Senokot(R) Tablets, Senokot-S(R) Tablets and SenokotXTRA(R) Tablets. The Purdue laxative portfolio is dedicated to providing consumers with specific solutions to the various types of occasional constipation that can occur as a part of everyday life.

(1) National Institute of Diabetes and Digestive and Kidney Diseases. (2007). National Digestive Diseases Information Clearing House: Constipation. Retrieved January 26, 2009, from http://digestive.niddk.nih.gov/ddiseases/pubs/constipation/Constipation.pdf

    Press Contact:
    Vicky Toporovsky
    Pollock Communications
    646.277.8719
    vtoporovsky@pollock-pr.com


'/>"/>
SOURCE Purdue Products L.P.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
2. Actavis Launches Carvedilol Tablets in the U.S.
3. Mylan Announces Final FDA Approval for Carvedilol Tablets
4. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
5. Actavis Launches Amlodipine Tablets in the U.S.
6. Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
7. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
8. KV Pharmaceutical Announces FDA Approval for Morphine ER 100 mg and 200 mg Tablets
9. Barrs Generic Version of Estrostep(R) Fe Tablets Approved
10. Ranbaxy Receives Tentative Approval For Valsartan Tablets
11. Barr Receives Tentative Approval for a Generic Version of Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg and 1.5mg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2015)... Ky. (PRWEB) , ... August 03, 2015 , ... A ... recurrence of some childhood cancers. The study is led by Kenneth G. Lucas, ... the University of Louisville in collaboration with colleagues at Kosair Children’s Hospital ...
(Date:8/1/2015)... (PRWEB) , ... August 02, 2015 , ... AlignLife ... which will help the continuity of care for patients at this natural health care ... the unknown," Clinic Director Mary Heal said. "Heather's role is vital to our approach ...
(Date:8/1/2015)... Humble, TX (PRWEB) , ... August 01, 2015 , ... ... common concern among both men and women often causing pain and discomfort. Those who ... to this circulatory problem, and Northeast Houston Vein Center is doing what it can ...
(Date:8/1/2015)... CT (PRWEB) , ... August 01, 2015 , ... ... Point Partners I, L.P. (“GPP”) portfolio company has acquired Premier Physical Therapy & ... it into its portfolio of state-of-the-art clinics. , “Our acquisition of Premier Physical ...
(Date:8/1/2015)... ... 2015 , ... “ reTXT ” was featured on NewsWatch as part of ... the market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and ... edit and delete any message including ones already sent. , While text messaging has ...
Breaking Medicine News(10 mins):Health News:UofL Physicians Conducting Vaccine Trial for Children with Relapsed Tumors at Kosair Children’s Hospital 2Health News:New Patient Advocate Enhances Natural Health Care 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2
... Senate to Introduce and Pass an Identical Bill, ... of Representatives for passing H.R. 1943, The Stop AIDS,in ... by Rep. Maxine Waters,(D-CA) in April would provide routine ... release from federal prisons and allow,inmates to request an ...
... found significant improvement in symptoms and productivity , , TUESDAY, ... who participated in a workplace program that used a ... improvement in their symptoms as well as greater productivity. ... in the Sept. 26 issue of the Journal ...
... Boise,s Leadership in the ... Premium and Specialty Papers Market, BENSENVILLE, Ill., Sept. ... announced that Boise(R) BEWARE(TM), an,anti-copy/anti-scan paper is in compliance with ... legislation,will go into affect on October 1, 2007. Boise(R) ...
... 25 Experts in health care and,technology investment ... technology-based economic growth in Ohio today at the ... These experts will help,shape Ohio,s future as it ... environment for the State of Ohio is changing," ...
... an eating disorder, it is not known whether there are ... Now, a new study finds that women with anorexia ... of the brain that is important for recognizing taste ... University of California, San Diego researchers currently on line in ...
... MANCHESTER, N.H., Sept. 25 Presidential,candidate Senator John ... cost-effective approach towards stopping HIV/AIDS in the US ... address violence against,women and to provide reproductive health ... ideas in Senator Edwards, plan,especially his proposal on ...
Cached Medicine News:Health News:House of Representatives Passes Stop AIDS in Prison Act of 2007 2Health News:Treatment Programs Benefit Depressed Workers 2Health News:Treatment Programs Benefit Depressed Workers 3Health News:Boise(R) BEWARE(TM) Meets New Federal Guidelines Set Forth by Medicaid 2Health News:Experts Agree. Ohio's Technology Investment Future Looks Bright 2Health News:Experts Agree. Ohio's Technology Investment Future Looks Bright 3Health News:Sense of taste different in women with anorexia nervosa 2Health News:Exciting New Plan from John Edwards on AIDS; Plan is 'Bold and Achievable,' say New Hampshire Activists 2
(Date:7/31/2015)... July 31, 2015 RnRMarketResearch.com ... market research report that provides an overview of ... data sourced from in-house databases, secondary and primary ... needles market products pipeline spread across 124 pages, ... 73 tables and 5 figures is now available ...
(Date:7/31/2015)... TAMPA, Fla. , July 31, 2015 /PRNewswire/ ... announced today that it has made a structured ... -based company specializing in milling, micronization and ... investment will help grow Powdersize,s business while simultaneously ... solutions to Xcelience,s portfolio of capabilities. ...
(Date:7/31/2015)... and SAN DIEGO , ... its parent company Eisai Co., Ltd. (Headquarters: ... , "Eisai") and Halozyme Therapeutics, Inc. (Headquarters: ... Helen Torley , "NASDAQ: HALO") have signed a ... name: Halaven ® , "eribulin") in combination with Halozyme,s ...
Breaking Medicine Technology:Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6
... 22 Xoft, makers of Electronic Brachytherapy systems ... integration of its Axxent® Electronic Brachytherapy System at the ... fully comprehensive breast center exclusively dedicated to the prevention, ... Lotus Breast Center is the first comprehensive breast center ...
... Baxano, Inc. ( www.baxano.com ) today announced the closing ... funding, led by new investor CMEA Capital.   Funds were also ... and existing investors Prospect Venture Partners, Three Arch Partners, and Kearny ... , ...
Cached Medicine Technology:Pink Lotus Breast Center to Integrate Electronic Brachytherapy Cancer Treatment Platform 2Pink Lotus Breast Center to Integrate Electronic Brachytherapy Cancer Treatment Platform 3Baxano, Inc. Announces Close of $30 Million Series C Funding 2
... camera system designed for scientific microscope ... digital cameras provides high-resolution, full-color images ... a PC via its Firewire (IEEE ... capability is accompanied by automatic white ...
... is a fully automatic fluorescence photomicrography system ... of even the most difficult specimens. Designed ... PM20 system provide solution to the complex ... their automatic exposure control, the system utilizes ...
... Digital camera systems for optimum image quality ... digital camera system is specifically designed for ... State-of-the-art electronics create bright, vibrant images without ... range offered by the Leica cameras allow ...
... for optimum image quality at low ... system records live cells, motion sequences ... times at the lowest light intensity. ... spectrum assure reliable results in GFP ...
Medicine Products: